TXMD TherapeuticsMD, Inc. Stock Quote

TXMD [NASD]

Healthcare | Drug Manufacturers - Specialty & Generic | USA

Index	-	P/E	-	EPS (ttm)	-0.71	Insider Own	11.21%	Shs Outstand	272.56M	Perf Week	-9.87%
Market Cap	538.36M	Forward P/E	-	EPS next Y	-0.33	Insider Trans	0.00%	Shs Float	266.15M	Perf Month	-18.93%
Income	-190.90M	PEG	-	EPS next Q	-0.10	Inst Own	42.70%	Short Float	27.30%	Perf Quarter	3.01%
Sales	58.20M	P/S	9.25	EPS this Y	-21.30%	Inst Trans	2.30%	Short Ratio	5.34	Perf Half Y	-4.86%
Book/sh	-0.43	P/B	-	EPS next Y	45.90%	ROA	-83.20%	Target Price	-	Perf Year	-23.89%
Cash/sh	0.20	P/C	6.76	EPS next 5Y	17.60%	ROE	310.20%	52W Range	0.85 - 2.75	Perf YTD	13.22%
Dividend	-	P/FCF	-	EPS past 5Y	-14.60%	ROI	-79.10%	52W High	-50.18%	Beta	1.97
Dividend %	-	Quick Ratio	2.40	Sales past 5Y	27.00%	Gross Margin	77.20%	52W Low	60.61%	ATR	0.21
Employees	348	Current Ratio	2.60	Sales Q/Q	-18.60%	Oper. Margin	-	RSI (14)	38.51	Volatility	13.44% 11.97%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	9.70%	Profit Margin	-	Rel Volume	1.37	Prev Close	1.30
Shortable	Yes	LT Debt/Eq	-	Earnings	Mar 02 BMO	Payout	-	Avg Volume	13.62M	Price	1.37
Recom	1.70	SMA20	-22.50%	SMA50	-11.58%	SMA200	-6.81%	Volume	18,653,101	Change	5.38%

Aug-07-20

Downgrade

Jefferies

Hold → Underperform

May-19-20

Downgrade

JP Morgan

Overweight → Neutral

Dec-02-19

Initiated

Guggenheim

Buy

Oct-17-19

Initiated

H.C. Wainwright

Buy

Apr-30-19

Resumed

Noble Capital Markets

Outperform

$13

Jun-15-18

Initiated

JP Morgan

Overweight

$11

Sep-08-17

Initiated

Morgan Stanley

Equal-Weight

Jul-11-17

Upgrade

Oppenheimer

Perform → Outperform

May-09-17

Downgrade

Oppenheimer

Outperform → Perform

Nov-22-16

Resumed

Jefferies

Buy

$18

Nov-22-16

Initiated

Oppenheimer

Outperform

Nov-07-16

Resumed

Guggenheim

Buy

Apr-04-16

Initiated

Goldman

Buy

$10

Dec-08-15

Reiterated

Stifel

Buy

$10 → $14

Dec-08-15

Reiterated

Jefferies

Buy

$15 → $18

Sep-21-15

Reiterated

Jefferies

Buy

$7 → $15

Jun-09-15

Initiated

Guggenheim

Buy

Jul-08-14

Initiated

FBR Capital

Outperform

$34

Apr-17-14

Reiterated

Noble Financial

Buy

$9 → $13

Jan-28-14

Reiterated

Noble Financial

Buy

$7.25 → $9

Mar-02-21 07:00PM	TherapeuticsMD, Inc. (TXMD) Q4 2020 Earnings Call Transcript Motley Fool
08:25AM	TherapeuticsMD (TXMD) Reports Q4 Loss, Tops Revenue Estimates Zacks
07:22AM	Recap: TherapeuticsMD Q4 Earnings Benzinga
07:00AM	TherapeuticsMD Announces Fourth Quarter and Full-Year 2020 Financial Results Business Wire
06:30AM	TherapeuticsMD, Inc. to Host Earnings Call ACCESSWIRE
Mar-01-21 10:05AM	TherapeuticsMD Earnings Preview Benzinga
07:00AM	TherapeuticsMD Announces Participation in Upcoming Investor Conferences Business Wire
Feb-23-21 04:05PM	TherapeuticsMD to Report Fourth Quarter 2020 Results on March 2, 2021 Business Wire
Feb-18-21 10:16AM	Here are the tough questions Congress needs to ask about GameStop today Yahoo Finance Video -5.41%
Feb-16-21 04:01PM	TherapeuticsMD Announces Closing of its Underwritten Public Offering of Common Stock Business Wire
12:02PM	What the GameStop Congressional hearing will reveal to retail investors Yahoo Finance
Feb-11-21 09:02AM	TherapeuticsMD Announces Pricing of $110 Million Public Offering of Common Stock Business Wire -11.52%
Feb-10-21 04:01PM	TherapeuticsMD Announces Underwritten Public Offering of its Common Stock Business Wire -14.90%
Feb-03-21 12:50PM	Is TherapeuticsMD (TXMD) Stock a Buy For 2021? Insider Monkey
Jan-29-21 03:29AM	TherapeuticsMD, Inc. (NASDAQ:TXMD) Analysts Just Cut Their EPS Forecasts Substantially Simply Wall St.
Jan-12-21 08:34AM	TherapeuticsMD (TXMD) Surges: Stock Moves 6.8% Higher Zacks
Dec-29-20 07:00AM	TherapeuticsMD Announces Participation in Upcoming Investor Conferences Business Wire
Dec-17-20 03:47AM	When Can We Expect A Profit From TherapeuticsMD, Inc. (NASDAQ:TXMD)? Simply Wall St.
Dec-15-20 08:13AM	Comedian Whitney Cummings Partners with TherapeuticsMD to Launch "Just Say Vagina" Business Wire +6.09%
Dec-11-20 10:34AM	Is TXMD A Good Stock To Buy Now? Insider Monkey
Nov-13-20 04:05PM	TherapeuticsMD Announces Closing of its Underwritten Public Offering of Common Stock Business Wire
07:00AM	TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference Business Wire
Nov-11-20 12:29PM	Analyst Estimates: Here's What Brokers Think Of TherapeuticsMD, Inc. (NASDAQ:TXMD) After Its Third-Quarter Report Simply Wall St.
Nov-10-20 08:58AM	TherapeuticsMD Announces Pricing of $30 Million Public Offering of Common Stock Business Wire -11.18%
Nov-09-20 04:01PM	TherapeuticsMD Announces Underwritten Public Offering of its Common Stock Business Wire +24.59%
03:00PM	TherapeuticsMD, Inc. (TXMD) Q3 2020 Earnings Call Transcript Motley Fool
08:15AM	TherapeuticsMD (TXMD) Reports Q3 Loss, Tops Revenue Estimates Zacks
07:28AM	TherapeuticsMD: Q3 Earnings Insights Benzinga
06:55AM	TherapeuticsMD® Announces Third Quarter 2020 Financial Results Business Wire
06:30AM	TherapeuticsMD, Inc. to Host Earnings Call ACCESSWIRE
Nov-02-20 12:31PM	Analysts Estimate TherapeuticsMD (TXMD) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-29-20 07:00AM	TherapeuticsMD to Report Third Quarter 2020 Results on November 9, 2020 Business Wire
Oct-28-20 12:33PM	Earnings Preview: TherapeuticsMD (TXMD) Q3 Earnings Expected to Decline Zacks
Oct-26-20 04:05PM	POPSUGAR Launches New Womens Health Destination, "Full Disclosure," in Collaboration With TherapeuticsMD Business Wire
10:01AM	ROCE Insights For TherapeuticsMD Benzinga
Oct-22-20 01:16PM	Should You Take Comfort From Insider Transactions At TherapeuticsMD, Inc. (NASDAQ:TXMD)? Simply Wall St.
Oct-09-20 08:00AM	TherapeuticsMD Supports the Importance of Empowering Women to Make Informed Choices about their Sexual and Reproductive Health Business Wire -6.25%
Oct-07-20 08:43AM	Implied Volatility Surging for TherapeuticsMD (TXMD) Stock Options Zacks
Oct-06-20 10:03AM	Looking Into TherapeuticsMD's Return On Capital Employed Benzinga
Oct-02-20 10:17AM	Return On Capital Employed Overview: TherapeuticsMD Benzinga
Sep-25-20 09:02AM	TherapeuticsMD Provides Update on Third Quarter Progress Business Wire +7.63%
Sep-21-20 05:01PM	Knight and TherapeuticsMD Announce Health Canada Approval of BIJUVA® GlobeNewswire
05:01PM	Knight and TherapeuticsMD Announce Health Canada Approval of BIJUVA® Business Wire
Sep-16-20 01:54PM	What Is The Ownership Structure Like For TherapeuticsMD, Inc. (NASDAQ:TXMD)? Simply Wall St.
Sep-10-20 06:50AM	TherapeuticsMD Announces Participation at Two Upcoming Virtual Investor Conferences Business Wire
Sep-09-20 04:05PM	TherapeuticsMD Announces Patent Updates for ANNOVERA® Business Wire
Aug-25-20 07:30AM	Knight and TherapeuticsMD Announce Health Canada Approval of IMVEXXY® Business Wire
Aug-14-20 10:34AM	Return On Capital Employed Overview: TherapeuticsMD Benzinga +7.74%
Aug-11-20 11:35AM	Bayer Buys KaNDy Therapeutics for $425 Million Up Front Motley Fool
Aug-06-20 09:45AM	TherapeuticsMD (TXMD) Reports Q2 Loss, Lags Revenue Estimates Zacks -21.46%
06:50AM	TherapeuticsMD® Announces Second Quarter 2020 Financial Results Business Wire
Jul-30-20 12:34PM	TherapeuticsMD (TXMD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Jul-29-20 06:50AM	TherapeuticsMD to Report Second Quarter 2020 Results on August 6, 2020 Business Wire
Jul-28-20 12:33PM	Will TherapeuticsMD (TXMD) Report Negative Q2 Earnings? What You Should Know Zacks -5.56%
Jul-15-20 06:50AM	TherapeuticsMD and Nurx Expand Access to ANNOVERA® Business Wire +10.07%
Jun-28-20 09:41AM	When Will TherapeuticsMD, Inc. (NASDAQ:TXMD) Breakeven? Simply Wall St.
Jun-25-20 04:49PM	Hedge Funds Are Dumping TherapeuticsMD Inc (TXMD) Insider Monkey +11.11%
Jun-01-20 06:50AM	TherapeuticsMD Announces Appointment of James C. DArecca as Chief Financial Officer and Retirement of Daniel A. Cartwright as Chief Financial Officer Business Wire +5.31%
May-27-20 09:47AM	Implied Volatility Surging for TherapeuticsMD (TXMD) Stock Options Zacks
May-25-20 09:36PM	Edited Transcript of TXMD earnings conference call or presentation 6-May-20 12:30pm GMT Thomson Reuters StreetEvents
May-08-20 06:50AM	TherapeuticsMD Announces Participation at the BofA Securities 2020 Health Care Conference Business Wire
May-07-20 12:00AM	TherapeuticsMD Inc (TXMD) Q1 2020 Earnings Call Transcript Motley Fool
May-06-20 09:35AM	TherapeuticsMD (TXMD) Reports Q1 Loss, Tops Revenue Estimates Zacks -7.58%
07:15AM	TherapeuticsMD: Q1 Earnings Insights Benzinga
06:50AM	TherapeuticsMD Announces First Quarter 2020 Financial Results Business Wire
Apr-29-20 03:00PM	Here's Why TherapeuticsMD Stock Is Rocketing Higher Today Motley Fool +78.01%
12:34PM	Analysts Estimate TherapeuticsMD (TXMD) to Report a Decline in Earnings: What to Look Out for Zacks
06:50AM	TherapeuticsMD Announces Issuance of First Orange Book Listable U.S. Patent for ANNOVERA® Business Wire
Apr-28-20 06:50AM	TherapeuticsMD to Report First Quarter 2020 Results on May 6, 2020 Business Wire
Apr-27-20 12:32PM	Earnings Preview: TherapeuticsMD (TXMD) Q1 Earnings Expected to Decline Zacks +5.89%
Apr-22-20 06:50AM	TherapeuticsMD Further Strengthens Board with Appointment of New Independent Director Business Wire
Mar-27-20 08:02AM	The Daily Biotech Pulse: Sanofi-Translate Bio Join Hands For Coronavirus Vaccine, TherapeuticsMD Suspends Guidance Benzinga -16.28%
Mar-26-20 04:05PM	TherapeuticsMD Provides COVID-19-Related Business Update Business Wire
Mar-24-20 07:45AM	TherapeuticsMD Strengthens Board with Appointment of Industry Leaders Business Wire +22.04%
Mar-16-20 06:00AM	TherapeuticsMD Provides Business Update on COVID-19 Pandemic Business Wire -15.44%
Mar-12-20 11:21AM	Is the Options Market Predicting a Spike in TherapeuticsMD (TXMD) Stock? Zacks -10.53%
Mar-11-20 06:25PM	Edited Transcript of TXMD earnings conference call or presentation 20-Feb-20 1:30pm GMT Thomson Reuters StreetEvents -5.59%
Mar-03-20 12:56PM	Analysts: These 3 Strong Buy Penny Stocks Could Gain Over 200% TipRanks
Feb-24-20 08:30AM	TherapeuticsMD, Inc. Yearly Results Just Came Out: Here's What Analysts Are Forecasting For Next Year Simply Wall St. -7.77%
Feb-20-20 08:15AM	TherapeuticsMD (TXMD) Reports Q4 Loss, Tops Revenue Estimates Zacks -10.42%
06:57AM	TherapeuticsMD Announces Fourth Quarter and Full-Year 2019 Financial Results Business Wire
06:30AM	TherapeuticsMD, Inc. to Host Earnings Call ACCESSWIRE
Feb-13-20 12:31PM	Earnings Preview: TherapeuticsMD (TXMD) Q4 Earnings Expected to Decline Zacks
06:30AM	TherapeuticsMD and Afaxys Enter Into Agreement to Expand Access to ANNOVERA® in the U.S. Public Health Sector Business Wire
Feb-10-20 06:30AM	TherapeuticsMD to Report Fourth Quarter 2019 Results on February 20, 2020 Business Wire
Feb-03-20 06:30AM	TherapeuticsMD Announces Submission of New Drug Application Prior Approval Efficacy Supplement to the U.S. Food and Drug Administration for Lower Dose of BIJUVA® Business Wire
Jan-15-20 10:37AM	How Much Are TherapeuticsMD, Inc. (NASDAQ:TXMD) Insiders Spending On Buying Shares? Simply Wall St.
Jan-07-20 06:30AM	TherapeuticsMD, An Innovative Women's Healthcare Company, And PlushCare, A Virtual Health Platform, Announce Enhanced Access To Women's Health Products PR Newswire
06:30AM	TherapeuticsMD, an Innovative Womens Healthcare Company, and PlushCare, a Virtual Health Platform, Announce Enhanced Access to Womens Health Products Business Wire
Jan-06-20 06:55AM	TherapeuticsMD Announces Participation at the JP Morgan Healthcare Conference Business Wire
Dec-30-19 06:55AM	TherapeuticsMD Announces Amendment to Term Loan Financing Facility with TPG Sixth Street Partners Business Wire
Dec-16-19 02:02PM	Do Hedge Funds Love TherapeuticsMD Inc (TXMD)? Insider Monkey +11.30%
Nov-26-19 07:30AM	Knight and TherapeuticsMD Announce Filing of New Drug Submission for BIJUVA® in Canada TEST Business Wire Releases
07:30AM	Knight and TherapeuticsMD Announce Filing of New Drug Submission for BIJUVA® in Canada Business Wire
Nov-23-19 01:08AM	Edited Transcript of TXMD earnings conference call or presentation 6-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-22-19 08:26AM	Introducing TherapeuticsMD (NASDAQ:TXMD), The Stock That Slid 63% In The Last Three Years Simply Wall St.
Nov-12-19 07:00AM	TherapeuticsMD Announces Participation at the Stifel 2019 Healthcare Conference Business Wire
Nov-06-19 07:05PM	TherapeuticsMD (TXMD) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:05PM	TherapeuticsMD Announces Third Quarter 2019 Financial Results Business Wire
Nov-04-19 10:37AM	Weekly CEO Buys Highlight GuruFocus.com

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; and TX-00THR and TX-0008HR, which are transdermal patch product candidates. The company's clinical development product is TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription prenatal vitamin and hormone therapy drug products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. is headquartered in Boca Raton, Florida.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Collins Cooper C.	Director	Jun 09	Buy	1.45	47,500	68,875	140,000	Jun 10 04:25 PM
Finizio Robert G	CEO	Jun 09	Buy	1.44	46,000	66,360	18,401,964	Jun 10 04:06 PM
Collins Cooper C.	Director	Jun 08	Buy	1.45	26,500	38,425	92,500	Jun 10 04:25 PM
Finizio Robert G	CEO	Jun 05	Buy	1.15	30,000	34,600	18,355,964	Jun 08 04:07 PM
Thompson Tommy G	Director	Jun 04	Buy	1.13	8,700	9,831	699,600	Jun 08 04:12 PM
BISARO PAUL	Director	Jun 04	Buy	1.14	50,000	57,000	50,000	Jun 08 04:10 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience